• 1. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 2. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 3. An approach for correlating the structural and electrical properties of Zr4+-modified SrBi4Ti4O15/SBT ceramic
  Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
• 4. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 5. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Bromobenzenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Halobenzenes Bromobenzenes

Recent Advances in the Application of 1-Bromo-4-(trichloromethyl)benzene (CAS: 17760-03-1) in Chemical Biology and Pharmaceutical Research

1-Bromo-4-(trichloromethyl)benzene (CAS: 17760-03-1) is a halogenated aromatic compound that has garnered significant attention in recent years due to its versatile applications in chemical biology and pharmaceutical research. This compound serves as a crucial intermediate in the synthesis of various bioactive molecules, including pharmaceuticals, agrochemicals, and materials science applications. Its unique chemical properties, such as the presence of both bromine and trichloromethyl groups, make it a valuable building block for constructing complex molecular architectures.

Recent studies have highlighted the role of 1-Bromo-4-(trichloromethyl)benzene in the development of novel drug candidates. For instance, researchers have utilized this compound as a key intermediate in the synthesis of potential anticancer agents. The bromine atom allows for further functionalization via cross-coupling reactions, while the trichloromethyl group can be transformed into other functional groups, such as carboxylic acids or amides, enhancing the compound's utility in medicinal chemistry.

In a groundbreaking study published in the Journal of Medicinal Chemistry, scientists demonstrated the use of 1-Bromo-4-(trichloromethyl)benzene in the synthesis of a new class of kinase inhibitors. These inhibitors showed promising activity against several cancer cell lines, with IC50 values in the nanomolar range. The study underscored the compound's potential as a scaffold for designing targeted therapies, particularly in oncology.

Another area of interest is the application of 1-Bromo-4-(trichloromethyl)benzene in materials science. Researchers have explored its use in the synthesis of organic semiconductors and liquid crystals. The compound's ability to undergo various transformations, such as Suzuki-Miyaura coupling and Buchwald-Hartwig amination, makes it a versatile precursor for designing advanced materials with tailored electronic and optical properties.

Despite its utility, the handling of 1-Bromo-4-(trichloromethyl)benzene requires careful consideration of safety protocols due to its potential toxicity and environmental impact. Recent advancements in green chemistry have focused on developing more sustainable methods for its synthesis and application, minimizing hazardous byproducts and improving overall efficiency.

In conclusion, 1-Bromo-4-(trichloromethyl)benzene (CAS: 17760-03-1) continues to be a valuable tool in chemical biology and pharmaceutical research. Its versatility as a synthetic intermediate, coupled with ongoing innovations in its application, positions it as a critical component in the development of next-generation therapeutics and materials. Future research is expected to further explore its potential, particularly in the context of personalized medicine and sustainable chemistry.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)